|
Home Page
About Us
Investors
Inventors
Portfolio
3DR Laboratories, LLC
AllTranz Inc.
AnosiaVax, Inc.
ApoImmune, Inc.
EndoProtech, Inc.
Eyevation, LLC
ImmunoTheragnostics Incorporated
InnoRem, Inc.
Intrepid Bioinformatics, Inc.
PGxl Laboratories, LLC
Pradama Inc.
RhinoCyte, Inc.
TrackFive Diagnostics, Inc.
ULSD, LLC
Contact Us
Privacy Policy
|
|
|
|
Portfolio - TrackFive Diagnostics, Inc.
| Incorporated: |
|
1Q 2009
|
Contacts:
|
|
Andrew Steen
|
| Scientific Founders: |
|
E. Penni Black, Ph.D.
Justin M. Balko, Pharm.D., Ph.D.
|
| Description: |
|
TrackFive will develop genomic-based clinical
diagnostic tests for cancer. TrackFive’s
first genomic-based test will predict which
metastatic colorectal cancer patients will
actually benefit from the drug Erbitux®. A
provisional patent application was filed 1Q09.
Company formed in partnership with MetaCyte, 1Q09
MetaCyte has engaged in discussions with potential strategic corporate partners.
|
|
|
